+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Individual Variability of Radionuclide Ventriculography in Stable Coronary Artery Disease Patients over One Year

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          To determine the individual reproducibility of radionuclide ventriculography over an extended period of time, 33 patients with stable coronary artery disease were studied at rest and during three stages of exercise on two occasions separated by 1 year. The individual interstudy variability of ejection fraction (EF), end-diastolic volume (EDV), end-systolic volume, and cardiac output was determined by calculating the mean and standard deviation of the difference between the individual studies (initial – 1 year). Despite high correlations between an EF measured at study 1 and study 2 of 0.96 at rest and 0.87 during maximal exercise, the individual interstudy difference was 0.01 ± 0.04 and-0.02 ± 0.09, respectively. The correlation of percent change in EF from rest to maximal exercise was 0.49 and the individual interstudy differences was -1.2 ± 19%. Correlations of the EDV were 0.81 at rest and 0.72 during maximal exercise while the individual difference was 0.7 ± 38 and-0.8 ± 49 ml, respectively. Considering two standard deviations as the confidence limits for a true change, an EF change of 8 EF units (0.08) at rest and 18 (0.18) during exercise, and EDV changes of approximately 100 ml are needed in an individual to state with confidence that the observed difference between the two studies are true changes and not the result of technologic variability. Because of the large individual interstudy variability in EF and volume measurement, caution must be taken in assuming that any change over a year is due to more than technique variability.

          Related collections

          Author and article information

          S. Karger AG
          11 November 2008
          : 71
          : 5
          : 255-265
          University of California, San Diego, Calif., USA
          173674 Cardiology 1984;71:255–265
          © 1984 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 11
          Original Paper


          Comment on this article